v3.26.3
Consolidated Statement Of Changes In Stockholders' Equity (Unaudited) - USD ($)
Total
Revision of Prior Period, Error Correction, Adjustment
Warrant
Common Stock
Common Stock
Warrant
Additional Paid-In Capital
Additional Paid-In Capital
Revision of Prior Period, Error Correction, Adjustment
Additional Paid-In Capital
Warrant
Accumulated Deficit
Series A Preferred
Preferred Stock
Series B Preferred
Preferred Stock
Series C Preferred
Preferred Stock
Series C Preferred
Common Stock
Beginning balance (in shares) at Dec. 31, 2024       77,076,129           5,875,000 0 770,000  
Beginning balance at Dec. 31, 2024 $ 20,182,026     $ 7,707   $ 74,256,138     $ (54,082,484) $ 588 $ 0 $ 77  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation - options 1,179,207         1,179,207              
Shares issued in exercise of stock options (in shares)       110,028                  
Stock options exercised 0     $ 11   (11)              
Sale of common stock, net of filing fees (in shares)       4,500,000                  
Sale of common stock, net of filing fees 3,995,928     $ 450   3,995,478              
Warrants exercised (in shares)         4,225,717                
Warrants exercised     $ 1,936,601   $ 423     $ 1,936,178          
Preferred stock conversion to common stock (in shares)       125,000                 (200,000)
Preferred stock conversion to common stock 1     $ 13   8             $ (20)
Net income (loss) for the period (1,197,031)               (1,197,031)        
Ending balance (in shares) at Mar. 31, 2025       86,036,874           5,875,000 0 570,000  
Ending balance at Mar. 31, 2025 26,096,732     $ 8,604   81,366,998     (55,279,515) $ 588 $ 0 $ 57  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation - options 640,021         640,021              
Sale of common stock, net of filing fees (in shares)       4,166,667                  
Sale of common stock, net of filing fees 4,470,406     $ 416   4,469,990              
Warrants exercised (in shares)         610,543                
Warrants exercised     639,770   $ 61     639,709          
Balance sheet reclassification adjustment   $ 274,500         $ 274,500            
Net income (loss) for the period (348,927)               (348,927)        
Ending balance (in shares) at Jun. 30, 2025       90,814,084           5,875,000 0 570,000  
Ending balance at Jun. 30, 2025 31,772,502     $ 9,081   87,391,218     (55,628,442) $ 588 $ 0 $ 57  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation - options 284,116         284,116              
Shares issued in exercise of stock options (in shares)       125,000                  
Stock options exercised 26,501     $ 13   26,488              
Warrants exercised (in shares)         3,673,666                
Warrants exercised     $ 4,257,111   $ 367     $ 4,256,744          
Net income (loss) for the period 388,582               388,582        
Ending balance (in shares) at Sep. 30, 2025       94,612,750           5,875,000 0 570,000  
Ending balance at Sep. 30, 2025 36,728,812     $ 9,461   91,958,566     (55,239,860) $ 588 $ 0 $ 57  
Beginning balance (in shares) at Dec. 31, 2025       94,612,750           5,875,000 0 570,000  
Beginning balance at Dec. 31, 2025 35,752,797     $ 9,461   92,330,909     (56,588,218) $ 588 $ 0 $ 57  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation - options 767,937         767,937              
Net income (loss) for the period (378,093)               (378,093)        
Ending balance (in shares) at Mar. 31, 2026       94,612,750           5,875,000 0 570,000  
Ending balance at Mar. 31, 2026 36,142,641     $ 9,461   93,098,846     (56,966,311) $ 588 $ 0 $ 57  
Beginning balance (in shares) at Dec. 31, 2025       94,612,750           5,875,000 0 570,000  
Beginning balance at Dec. 31, 2025 $ 35,752,797     $ 9,461   92,330,909     (56,588,218) $ 588 $ 0 $ 57  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued in exercise of stock options (in shares) 150,000                        
Ending balance (in shares) at Sep. 30, 2026       94,931,286           5,875,000 0 570,000  
Ending balance at Sep. 30, 2026 $ 36,335,534     $ 9,493   94,825,846     (58,500,450) $ 588 $ 0 $ 57  
Beginning balance (in shares) at Mar. 31, 2026       94,612,750           5,875,000 0 570,000  
Beginning balance at Mar. 31, 2026 36,142,641     $ 9,461   93,098,846     (56,966,311) $ 588 $ 0 $ 57  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation - options 756,383         756,383              
Shares issued in exercise of stock options (in shares)       150,000                  
Stock options exercised 52,500     $ 15   52,485              
Employee stock purchase plan (in shares)       86,189                  
Employee stock purchase plan 39,164     $ 9   39,155              
Net income (loss) for the period (1,053,416)               (1,053,416)        
Ending balance (in shares) at Jun. 30, 2026       94,698,939           5,875,000 0 570,000  
Ending balance at Jun. 30, 2026 35,884,772     $ 9,470   93,894,384     (58,019,727) $ 588 $ 0 $ 57  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation - options 819,695         819,695              
Employee stock purchase plan (in shares)       82,347                  
Employee stock purchase plan 59,290     $ 8   59,282              
Net income (loss) for the period (480,723)               (480,723)        
Ending balance (in shares) at Sep. 30, 2026       94,931,286           5,875,000 0 570,000  
Ending balance at Sep. 30, 2026 $ 36,335,534     $ 9,493   $ 94,825,846     $ (58,500,450) $ 588 $ 0 $ 57